Tectonic Therapeutic (TECX) has had the highest return since January 1, 2024 by a US stock with a market cap of $2,023+, returning 5,979,275%.
| ASSET | % RETURN |
|---|---|
Tectonic Therapeutic (TECX) | 5,979,275% |
Iteris (ITI) | 5,295.93% |
TSS, Inc Common Stock (TSSI) | 3,396.3% |
GeneDx (WGS) | 2,882.22% |
Bright Minds Biosciences (DRUG) | 2,457.72% |
LENZ Therapeutics (LENZ) | 1,969.89% |
Sezzle Inc Common Stock (SEZL) | 1,940.26% |
Fitell Corporation Ordinary Shares (FTEL) | 1,609.87% |
Zivo Bioscience (ZIVO) | 1,420.74% |
Mobiquity Technologies (MOBQ) | 1,088.95% |
Monopar Therapeutics (MNPR) | 1,075.23% |
Dave (DAVE) | 978.4% |
Root (ROOT) | 877.54% |
Palladyne AI (PDYN) | 864.68% |
Exicure (XCUR) | 842.8% |
Red Cat (RCAT) | 839.33% |
Laird Superfood (LSF) | 821.19% |
Nexalin Technology (NXL) | 818.85% |
Eco Wave Power Global AB ADR (WAVE) | 807.03% |
Applovin (APP) | 736.77% |
Dogness International Corp Class A (DOGZ) | 716.42% |
Nuscale Power (SMR) | 712.96% |
Kingstone Companies (KINS) | 710.15% |
Wang & Lee Group, Inc Ordinary Shares (WLGS) | 648.25% |
Summit Therapeutics (SMMT) | 644.19% |
